Checking out GENZ for a trade.  Larger biotech, multiple products on the market, two recent approvals.  This is the kind of the bio I am gravitating more to this year.  Trying to sort through the obvious consolidation that will occur in 2009/2010 and pick a company with sales, pipeline, and potential combination with other entities utility.  I like its current chart overall.  Its pattern is downward, but does not seem to be any structural reason for it.  This ticker also has lots of talk of a buyout of BMRN within the market and biotech world!!

 

There is a big biotech meeting going on this week-may generate good news-if it drops much further I might get 100 and play it?  We will see.?  On my closely watched list.

 

Avoiding FDA decisions in small bio tickers after AMAG!

 

This company hangs in an area with CELG, DNA, AMGN, GILD, DNA, and even CEPH.  They all have hefty PPS but they deserve it-they are mid to large cap stocks in this space!

 

Kutz